| Quote | Spy ARRY NEW ![]() |
Message Board | |||||
|
Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders. |
|
OSI Brushes Off Hostile Bid, Cancer Stocks Surge
OSIP ARIA ARRY ZGEN ANX Linked by tickerspy blog - March 01, 12:48PM from (www.tickerspy.com) OSI Pharmaceuticals (OSIP) soared by over 50% on Monday after receiving an unsolicited buyout bid from Astellas Pharma (OTC: ALPMY) worth $52 per share. more ...
Home Diagnostics Buyout Powers Diabetes Segment
NVO AMLN HDIX MNKD GNBT ARRY Linked by tickerspy blog - February 03, 12:03PM from (www.tickerspy.com) Home Diagnositics (HDIX) is soaring today after the company announced a definitive merger agreement with Nipro Corporation. more ...
Array BioPharma Tops Q2 Views
ARRY Linked by StreetInsider - February 01, 04:33PM from (www.streetinsider.com) more ...
Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2010
ARRY Linked by BusinessWire - February 01, 04:33PM from (www.businesswire.com) Array BioPharma Inc. (Nasdaq: ARRY) today reported financial results for the second quarter of fiscal 2010. Array reported more ...
Array BioPharma Names Bengt Bergstrom, M.D., Ph.D., Vice President, Clinical Development
ARRY Linked by BusinessWire - January 26, 04:01PM from (www.businesswire.com) Array BioPharma Inc. (NASDAQ: ARRY) today announced that Bengt Bergstrom, M.D., has joined the Company as Vice President more ...
Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2010 on February 1, 2010
ARRY Linked by BusinessWire - January 25, 05:01PM from (www.businesswire.com) Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the second quarter of fiscal 2010 on Monday, February more ...
Array Biopharma Gets Lucky
AMGN ARRY Linked by 24/7 Wall St. - December 15, 10:23AM from (247wallst.com) Small biopharma stocks sometimes have that one big day, the day that there investors wait for. Array Biopharma (NASDAQ:ARRY) more ...
Huge Leaps for Small-Cap Pharma Plays
NABI AMGN MNKD DEPO GNBT CYTX ARRY CRIS JAZZ BIOD Linked by tickerspy blog - December 15, 10:04AM from (www.tickerspy.com) Shares of Array BioPharma (ARRY) surged on Tuesday after the small-cap company signed a $60 million deal. more ...
Top Day Trader Alerts
WFC GILD ARRY JASO LIMS Linked by 24/7 Wall St. - December 15, 08:31AM from (247wallst.com) This morning's top day trader and active trader alerts are below with links to VSInvestor.com on each stock story with more detailed data and analysis: more ...
Array BioPharma and Amgen Partner in Type 2 Diabetes
AMGN ARRY Linked by BusinessWire - December 14, 06:15PM from (www.businesswire.com) Array BioPharma Inc. (NASDAQ: ARRY) and Amgen Inc.(NASDAQ: AMGN) today announced that they entered into an agreement granting more ...
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2010 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF.
|
|